You are here

  • Home
  • Archive
  • Volume 7, Issue 6
  • Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority cli…

Citation Tools

Article menu

Download PDFPDF

XML
Infectious diseases
Protocol
Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
López-Cortés LE, Rosso-Fernández C, Núñez-Núñez M the SIMPLIFY Study Group, et al
Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial
BMJ Open 2017;7:e015439. doi: 10.1136/bmjopen-2016-015439